Clinical practice guidelines for the management of chronic kidney disease stages 3b, 4 and 5 in the Peruvian Health Social Security

被引:0
|
作者
Bravo-Zuniga, Jessica [1 ]
Garcia-Gomero, David [2 ]
Dolores-Maldonado, Gandy [2 ]
Hinostroza-Sayas, Juana [3 ]
Chavez-Gomez, Jorge [1 ]
Medina-Sal y Rosas, Carola
Meneses-Liendo, Victor
Pereda-Vejarano, Carlos [3 ]
Gonzales-Haro, Fernando [4 ]
Perez-Arteaga, Luis [5 ]
Loza-Munarris, Cesar [6 ]
Medina-Santander, Boris [7 ]
Chaud-Covarrubias, Rosana [8 ]
Hancco-Saavedra, Jorge [9 ]
Taype-Rondan, Alvaro [2 ,10 ]
Salvador-Salvador, Stefany [2 ]
Acosta, Lourdes Carrera [2 ]
机构
[1] EsSalud, Hosp Nacl Edgardo Rebagliati Martins, Lima, Peru
[2] EsSalud, Inst Evaluac Tecnol Salud & Invest IETSI, Peru Jiron Domingo Cueto 109, Lima, Peru
[3] EsSalud, Ctr Nacl Salud Renal, Lima, Peru
[4] EsSalud, Hosp Nacl Alberto Sabogal Sologuren, Lima, Peru
[5] EsSalud, Hosp Nacl Guillermo Almenara Irigoyen, Lima, Peru
[6] Minsa, Hosp Nacl Cayetano Heredia, Lima, Peru
[7] MINSA, Hosp Nacl Arzobispo Loayza, Lima, Peru
[8] FISSAL, Fondo Intangible Solidario Salud, Lima, Peru
[9] MINSA, Componente Prevenc & Control Danos Transmisibles, DENOT DGIESP, Lima, Peru
[10] Univ San Ignacio Loyola, Unidad Invest Generac & Sintesis Evidencias Salud, Vicerrectorado Invest, Lima, Peru
关键词
chronic kidney disease; clinical practice guidelines; GRADE; evidence-based medicine; DIALYSIS; CARE; INTERVENTIONS; PROGRESSION; ASSOCIATION; OUTCOMES; THERAPY; RISK;
D O I
10.35434/rcmhnaaa.2023.161.1709
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: This article summarizes the clinical practice guideline (CPG) for the management of stage 3b, 4, and 5 chronic kidney disease (CKD) in the Social Security of Peru (EsSalud). Objective: To provide evidence-based clinical recommendations for the management of stage 3b, 4, and 5 CKD in EsSalud.Methods: A guideline development group (GDG) was formed, including specialists and methodologists. The GDG formulated 9 clinical questions. Systematic searches for systematic reviews and primary studies were conducted in PubMed from December 2020 to August 2021. Evidence was selected to answer the clinical questions posed. The certainty of the evidence was evaluated using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) methodology. The GDG used the GRADE methodology to review the evidence and formulate recommendations, points of good clinical practice (GPC), and management flowcharts. Finally, the CPG was approved with Resolution No. 88-IETSI-ESSALUD-2021.Results: This CPG addressed 9 clinical questions. Based on these questions, 17 recommendations (7 strong and 10 conditional), 28 GPC points, and 4 management flowcharts were formulated.Conclusion: This article summarizes the methodology and evidence-based conclusions of the CPG for the management of stage 3b, 4, and 5 CKD in EsSalud.
引用
下载
收藏
页数:19
相关论文
共 50 条
  • [41] Ministry of Health Clinical Practice Guidelines: Chronic Hepatitis B Infection
    Chow, W. C.
    Chong, R.
    Guan, R.
    Ho, K. Y. L.
    Leo, Y. S.
    Loy, K. L.
    Lui, H. F.
    Ng, H. S.
    Siew, W. F.
    Teo, E. K.
    Yeo, T.
    SINGAPORE MEDICAL JOURNAL, 2011, 52 (04) : 307 - 313
  • [42] Clinical practice guidelines for chronic kidney disease in adults: Part I. Definition, disease stages, evaluation, treatment, and risk factors
    Johnson, CA
    Levey, AS
    Coresh, J
    Levin, A
    Lau, J
    Eknoyan, G
    AMERICAN FAMILY PHYSICIAN, 2004, 70 (05) : 869 - 876
  • [43] Ministry of Health Clinical Practice Guidelines: Chronic Obstructive Pulmonary Disease
    Lim, Tow Keang
    Chee, Cynthia
    Chow, Patsy
    Chua, Gerald
    Eng, Soo Kiang
    Goh, Soon Keng
    Kng, Kwee Keng
    Lim, Wai Hing
    Ng, Tze Pin
    Ong, Thun How
    Seah, Angeline
    Tan, Hsien Yung David
    Tee, Augustine
    Palanichamy, Vimal
    Yeung, Meredith
    SINGAPORE MEDICAL JOURNAL, 2018, 59 (02) : 76 - 86
  • [44] Comments on KDIGO clinical practice guidelines for bisphosphonate treatment of chronic kidney disease
    Przedlacki, Jerzy
    KIDNEY INTERNATIONAL, 2010, 78 (11) : 1186 - 1186
  • [45] Clinical practice guidelines in nephrology: Evaluation, classification, and stratification of chronic kidney disease
    Bailie, GR
    Uhlig, K
    Levey, AS
    PHARMACOTHERAPY, 2005, 25 (04): : 491 - 502
  • [46] ARE TRIAL-BASED CLINICAL PRACTICE GUIDELINES POSSIBLE IN CHRONIC KIDNEY DISEASE?
    Tong, A.
    Campbell, D.
    Craig, J. C.
    NEPHROLOGY, 2007, 12 : A41 - A42
  • [47] Quality assessment of clinical practice guidelines for chronic kidney disease: a systematic review
    Coronado Daza, Jorge
    Vernooij, Robin W. M.
    Salas, Karla
    Osorio, Dimelza
    Urrutia Cuchi, Gerard
    BMC NEPHROLOGY, 2019, 20 (1)
  • [48] Quality assessment of clinical practice guidelines for chronic kidney disease: a systematic review
    Jorge Coronado Daza
    Robin W. M. Vernooij
    Karla Salas
    Dimelza Osorio
    Gerard Urrútia Cuchí
    BMC Nephrology, 20
  • [49] Chronic kidney disease among elderly patients: Are clinical practice guidelines implemented?
    Budhiraja, P
    Van Wyck, DB
    Fain, MJ
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2006, 54 (04) : S182 - S182
  • [50] The 2020 Updated KDOQI Clinical Practice Guidelines for Nutrition in Chronic Kidney Disease
    Ikizler, Talat Alp
    Cuppari, Lilian
    BLOOD PURIFICATION, 2021, 50 (4-5) : 667 - 671